ArticleOncology letters2022

Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid-based antisense: A potential new drug candidate for pancreatic cancer.

Ayelet Shai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.